HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Submit a response Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hays, J T Articles by Davidson, M Search for Related Content PubMed PubMed Citation Articles by Hays, J T Articles by Davidson, M

Over-the-counter nicotine patch therapy for smoking cessation: results from randomized, double-blind, placebo-controlled, and open label trials.

J T Hays, I T Croghan, D R Schroeder, K P Offord, R D Hurt, T D Wolter, M A Nides and M Davidson

Mayo Clinic, Rochester, MN 55905, USA. hays.taylor@mayo.edu

OBJECTIVES: The purpose of this study was to determine the efficacy and safety of the nicotine patch for smoking cessation in an over-the-counter environment. The years of study were 1994 to 1995. METHODS: Parallel 6-week trials were conducted: a placebo-controlled trial of no-cost 22-mg, 24-hour nicotine patch therapy and an open label trial of the same therapy with patches purchased by subjects. Participants (n = 958) were 18 years or older, had smoked at least 15 cigarettes daily for at least 6 months, and were enrolled at 3 study sites. The main outcome measure was self-reported smoking abstinence confirmed by expired carbon monoxide measurements. RESULTS: Smoking cessation rates in the placebo-controlled trial were 16.8% and 9.6% at week 6 and 8.7% and 4.3% at week 24 for the active patch and placebo groups, respectively. Smoking cessation rates in the open label-pay trial were 19.0% and 10.8% at weeks 6 and 24, respectively. A slight increase in adverse cardiovascular events was noted only in the open label-pay group in comparison with the placebo group. CONCLUSIONS: In an over-the-counter environment, the 22-mg, 24-hour nicotine patch is effective and safe for smoking cessation treatment.

This article has been cited by other articles:

				M. J. Eisenberg MD MPH, K. B. Filion MSc, D. Yavin BSc, P. Belisle MSc, S. Mottillo BSc, L. Joseph PhD, A. Gervais MD, J. O'Loughlin PhD, G. Paradis MD MSc, S. Rinfret MD MSc, et al. Pharmacotherapies for smoking cessation: a meta-analysis of randomized controlled trials Can. Med. Assoc. J., July 15, 2008; 179(2): 135 - 144. [Abstract] [Full Text] [PDF]

				R A Walsh, L. Stead, and T. Lancaster The Cochrane review on nicotine replacement therapy: incorrect or uncertain classifications of additional support levels * Authors' response Tob. Control, June 1, 2007; 16(3): 215 - 216. [Full Text] [PDF]

				M. B. Reed, C. M. Anderson, J. W. Vaughn, and D. M. Burns The Effect of Over-the-Counter Sales of the Nicotine Patch and Nicotine Gum on Smoking Cessation in California Cancer Epidemiol. Biomarkers Prev., September 1, 2005; 14(9): 2131 - 2136. [Abstract] [Full Text] [PDF]

				K. Resnicow, F. McCarty, and T. Baranowski Are precontemplators less likely to change their dietary behavior? A prospective analysis Health Educ. Res., December 1, 2003; 18(6): 693 - 705. [Abstract] [Full Text] [PDF]

				J R Hughes, S Shiffman, P Callas, and J Zhang A meta-analysis of the efficacy of over-the-counter nicotine replacement Tob. Control, March 1, 2003; 12(1): 21 - 27. [Abstract] [Full Text] [PDF]

				D. A. Grimes Switching Emergency Contraception to Over-the-Counter Status N. Engl. J. Med., September 12, 2002; 347(11): 846 - 849. [Full Text] [PDF]

				J. P. Pierce and E. A. Gilpin Impact of Over-the-Counter Sales on Effectiveness of Pharmaceutical Aids for Smoking Cessation JAMA, September 11, 2002; 288(10): 1260 - 1264. [Abstract] [Full Text] [PDF]

				S Hand, S Edwards, I A Campbell, and R Cannings Controlled trial of three weeks nicotine replacement treatment in hospital patients also given advice and support Thorax, August 1, 2002; 57(8): 715 - 718. [Abstract] [Full Text] [PDF]

				D T Levy and K Friend Examining the effects of tobacco treatment policies on smoking rates and smoking related deaths using the SimSmoke computer simulation model Tob. Control, March 1, 2002; 11(1): 47 - 54. [Abstract] [Full Text] [PDF]

				R. West, A. McNeill, and M. Raw Smoking cessation guidelines for health professionals: an update Thorax, December 1, 2000; 55(12): 987 - 999. [Abstract] [Full Text]